Hologic Inc. logo

HOLX

Hologic Inc.

$80.5

Earnings Summary

Revenue
$1074.2Mn
Net Profits
$187.4Mn
Net Profit Margins
17.45%
PE Ratio
20

Highlights

Revenue:

Hologic Inc.’s revenue fell -26.98% since last year same period to $1074.2Mn in the Q4 2022. On a quarterly growth basis, Hologic Inc. has generated 12.68% jump in its revenue since last 3-months.

Net Profits:

Hologic Inc.’s net profit fell -62.46% since last year same period to $187.4Mn in the Q4 2022. On a quarterly growth basis, Hologic Inc. has generated 57.88% jump in its net profits since last 3-months.

Net Profit Margins:

Hologic Inc.’s net profit margin fell -48.59% since last year same period to 17.45% in the Q4 2022. On a quarterly growth basis, Hologic Inc. has generated 40.11% jump in its net profit margins since last 3-months.

PE Ratio:

Hologic Inc.’s price-to-earnings ratio after this Q4 2022 earnings stands at 20.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Hologic Inc. post its latest quarter earnings

EPS Estimate Current Quarter
0.86
EPS Estimate Current Year
0.86

Highlights

EPS Estimate Current Quarter:

Hologic Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.86 - a 36.51% jump from last quarter’s estimates.

EPS Estimate Current Year:

Hologic Inc.’s earning per share (EPS) estimates for the current year stand at 0.86.

Key Ratios

Key ratios of the Hologic Inc. post its Q4 2022 earnings

Return on Assets (ROA)
0.09
Return on Equity (ROE)
0.21

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Hologic Inc.’s return on assets (ROA) stands at 0.09.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Hologic Inc.’s return on equity (ROE) stands at 0.21.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-07-27
0.71
0.95
33.8%
2022-04-27
1.6
2.07
29.37%
2022-11-15
0.63
0.82
30.16%

Company Information

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.

Organisation
Hologic Inc.
Headquarters
250 Campus Drive, Marlborough, MA, United States, 01752
Employees
6944
Industry
Health Technology
CEO
Stephen MacMillan